Dainippon Sumitomo Pharma Co., Ltd. - Financial and Strategic Analysis Review

Summary

Dainippon Sumitomo Pharma Co., Ltd. - Financial and Strategic Analysis Review

Summary

Dainippon Sumitomo Pharma Co., Ltd. (DSP) is a Japan-based pharmaceutical company engaged in manufacturing and selling pharmaceuticals, veterinary products, food additives, industrial chemicals, and other chemical products. The company conducts its sales and marketing operations through 22 branches and 55 sales offices through out Japan. The company carries out its operations through 11 subsidiaries and seven associated companies. It is headquartered in Osaka-shi, Osaka, Japan. In January 2009, the company's Parkinson's disease drug "TRERIEF" received manufacturing and marketing approval. In March 2009, it launched "PRONAMID",a gastro-prokinetic agent for dogs.

Global Markets Direct's Dainippon Sumitomo Pharma Co., Ltd. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Dainippon Sumitomo Pharma Co., Ltd.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• List of Tables
• List of Figures
  • Dainippon Sumitomo Pharma Co., Ltd. - Key Facts
  • Dainippon Sumitomo Pharma Co., Ltd. - Business Description
  • Dainippon Sumitomo Pharma Co., Ltd. - Major Products and Services
  • Dainippon Sumitomo Pharma Co., Ltd. - History
  • Dainippon Sumitomo Pharma Co., Ltd. - SWOT Analysis
  • SWOT Analysis - Overview
  • Dainippon Sumitomo Pharma Co., Ltd. - Strengths
  • Strength - Extensive Product Portfolio
  • Strength - Adequate Manufacturing Facilities
  • Strength - Strategic R&D Approach
  • Dainippon Sumitomo Pharma Co., Ltd. - Weaknesses
  • Weakness - Discontinued Development of Products
  • Weakness - Declining Operating Margin
  • Weakness - Low Return on Equity
  • Dainippon Sumitomo Pharma Co., Ltd. - Opportunities
  • Opportunity - Changing Demographics
  • Opportunity - Robust Pipeline Products
  • Opportunity - New product launches
  • Opportunity - Large Market for CNS Disorders and Diabetes
  • Dainippon Sumitomo Pharma Co., Ltd. - Threats
  • Threat - Impact of Pricing Control
  • Threat - Competition from Western Pharmaceutical Companies
  • Threat - Regulation
  • Threat - Emergence of Biogenerics and Biosimilars
  • Dainippon Sumitomo Pharma Co., Ltd. - Key Competitors
  • Dainippon Sumitomo Pharma Co., Ltd. - Key Employees
  • Dainippon Sumitomo Pharma Co., Ltd. - Key Employee Biographies
  • Dainippon Sumitomo Pharma Co., Ltd. - Company Statement
  • Dainippon Sumitomo Pharma Co., Ltd. - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Dainippon Sumitomo Pharma Co., Ltd. - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Dainippon Sumitomo Pharma Co., Ltd., Key Facts
  • Dainippon Sumitomo Pharma Co., Ltd., Major Products and Services
  • Dainippon Sumitomo Pharma Co., Ltd., History
  • Dainippon Sumitomo Pharma Co., Ltd., Key Employees
  • Dainippon Sumitomo Pharma Co., Ltd., Key Employee Biographies
  • Dainippon Sumitomo Pharma Co., Ltd., Other Locations
  • Dainippon Sumitomo Pharma Co., Ltd., Ratios based on current share price
  • Dainippon Sumitomo Pharma Co., Ltd., Annual Ratios
  • Dainippon Sumitomo Pharma Co., Ltd., Interim Ratios
• List of Figures
  • Dainippon Sumitomo Pharma Co., Ltd., Ratio Charts